Guangjian Lu

427 total citations
19 papers, 354 citations indexed

About

Guangjian Lu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Guangjian Lu has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Guangjian Lu's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Guangjian Lu is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Guangjian Lu collaborates with scholars based in China. Guangjian Lu's co-authors include Pengju Ma, Dawei Xu, Wenyu Di, Yi Zhang, Bing Zhou, Weixin Wang, Yanjun Zhou, Xiaodong Yang, Guojun Gao and Lijiang Wang and has published in prestigious journals such as Scientific Reports, FEBS Letters and Bioconjugate Chemistry.

In The Last Decade

Guangjian Lu

19 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangjian Lu China	13	271	232	47	39	27	19	354
Yazdan Rahmati Iran	9	257 0.9×	133 0.6×	28 0.6×	24 0.6×	70 2.6×	19	333
Parisa Naeli Iran	10	444 1.6×	377 1.6×	33 0.7×	18 0.5×	31 1.1×	21	536
Nina Gennebäck Sweden	3	405 1.5×	226 1.0×	37 0.8×	22 0.6×	16 0.6×	4	442
Yanyin Lu Japan	7	275 1.0×	122 0.5×	49 1.0×	17 0.4×	39 1.4×	10	334
Chang Niu China	8	254 0.9×	72 0.3×	28 0.6×	24 0.6×	61 2.3×	13	329
Hak Kyun Kim South Korea	9	722 2.7×	481 2.1×	27 0.6×	13 0.3×	18 0.7×	16	791
Peng Fu China	8	197 0.7×	151 0.7×	35 0.7×	16 0.4×	43 1.6×	17	290
Shuanglin Han Australia	6	180 0.7×	141 0.6×	72 1.5×	9 0.2×	66 2.4×	7	293
Shi Li China	10	239 0.9×	204 0.9×	23 0.5×	42 1.1×	38 1.4×	27	350

Countries citing papers authored by Guangjian Lu

Since Specialization

Citations

This map shows the geographic impact of Guangjian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangjian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangjian Lu more than expected).

Fields of papers citing papers by Guangjian Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangjian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangjian Lu. The network helps show where Guangjian Lu may publish in the future.

Co-authorship network of co-authors of Guangjian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangjian Lu. A scholar is included among the top collaborators of Guangjian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangjian Lu. Guangjian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhao, Jinjin, et al.. (2025). Tumor Cell Membrane Biomimetic Mesoporous Silicon Materials in Combination with PD-L1 Knockout Achieved through the CRISPR/Cas9 System for Targeted and Immunotherapeutic Purposes. Bioconjugate Chemistry. 36(5). 971–979. 2 indexed citations

Zhao, Jinjin, Haiguang Zhang, Yaqian Liu, et al.. (2024). HIF-1α knockdown suppresses breast cancer metastasis via epithelial mesenchymal transition Abrogation. Heliyon. 10(19). e37900–e37900. 2 indexed citations

Guo, Chun, Jiaqi Dong, Jie Zhang, et al.. (2021). Glyoxal damages human aortic endothelial cells by perturbing the glutathione, mitochondrial membrane potential, and mitogen-activated protein kinase pathways. BMC Cardiovascular Disorders. 21(1). 603–603. 8 indexed citations

Wang, Haifeng, Lijiang Wang, Yan Liu, et al.. (2021). Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer. Aging. 13(10). 14456–14468. 51 indexed citations

Wang, Weixin, et al.. (2019). MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4. International Journal of Molecular Medicine. 44(1). 185–195. 30 indexed citations

Lin, Xuefeng, et al.. (2019). MicroRNA-132-3p suppresses type I IFN response through targeting IRF1 to facilitate H1N1 influenza A virus infection. Bioscience Reports. 39(12). 22 indexed citations

Wang, Weixin, et al.. (2019). MicroRNA‑199a‑5p functions as a tumor suppressor in oral squamous cell carcinoma via targeting the IKKβ/NF‑κB signaling pathway. International Journal of Molecular Medicine. 43(4). 1585–1596. 25 indexed citations

Xu, Dawei, Ruihua Liu, Lei Meng, et al.. (2018). Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489. Biomedicine & Pharmacotherapy. 100. 20–28. 19 indexed citations

Xu, Dawei, et al.. (2018). LncRNA DANCR functions as a competing endogenous RNA to regulate RAB1A expression by sponging miR-634 in glioma. Bioscience Reports. 38(1). 44 indexed citations

10.

Yang, Bo, Di Song, Yue Liu, et al.. (2018). IFI16 regulates HTLV‐1 replication through promoting HTLV‐1 RTI‐induced innate immune responses. FEBS Letters. 592(10). 1693–1704. 12 indexed citations

11.

Wang, Jie, Di Song, Guangjian Lu, et al.. (2017). HLA-DMB restricts human T-cell leukemia virus type-1 (HTLV-1) protein expression via regulation of ATG7 acetylation. Scientific Reports. 7(1). 14416–14416. 5 indexed citations

12.

Di, Wenyu, et al.. (2015). High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells. Tumor Biology. 36(12). 9245–9249. 30 indexed citations

13.

Lu, Guangjian, et al.. (2015). Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study. Tumor Biology. 36(11). 8645–8652. 13 indexed citations

14.

Lu, Guangjian, et al.. (2015). miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.. PubMed. 8(5). 5224–9. 26 indexed citations

15.

Zhou, Bing, et al.. (2014). Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.. PubMed. 7(12). 8893–8. 33 indexed citations

16.

Qi, Xiaofen, et al.. (2013). Effect of traditional Chinese medicine (Xiaochaihu Tang) on the expression of MMP-2 and MMP-9 in rats with endometriosis. Experimental and Therapeutic Medicine. 6(6). 1385–1389. 13 indexed citations

17.

Wang, Haifeng, et al.. (2013). Clinical value of a whole blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection during antitubercular treatment. Experimental and Therapeutic Medicine. 6(2). 455–458. 3 indexed citations

18.

Lu, Guangjian, et al.. (2013). Aptamer and graphene‐based electrochemical biosensor for dopamine determination with high sensitivity and selectivity. Micro & Nano Letters. 8(12). 903–905. 15 indexed citations

19.

Lu, Guangjian, et al.. (2011). [Clinical study of dynamic change of inflammatory factors in serum of acute paraquat rats].. PubMed. 29(3). 227–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact